BlackRock’s Oragenics OGEN Stock Holding History

BlackRock’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$394	Hold	703	–	–	﹤0.01%	5578
2025 Q4	$551	Hold	703	–	–	﹤0.01%	5438
2025 Q3	$921	Buy	703 +2	+0.3%	+$3	﹤0.01%	5352
2025 Q2	$2.68K	Sell	701 -1	-0.1%	-$5	﹤0.01%	5309
2025 Q1	$4.42K	Hold	702	–	–	﹤0.01%	5252
2024 Q4	$7.78K	Hold	702	–	–	﹤0.01%	5191
2024 Q3	$8.03K	Hold	702	–	–	﹤0.01%	5001
2024 Q2	$21.9K	Hold	702	–	–	﹤0.01%	5000
2024 Q1	$30.3K	Sell	702 -36	-5%	-$3.55K	﹤0.01%	4966
2023 Q4	$125K	Hold	738	–	–	﹤0.01%	4752
2023 Q3	$65.8K	Hold	738	–	–	﹤0.01%	4949
2023 Q2	$73.3K	Hold	738	–	–	﹤0.01%	5000
2023 Q1	$72.9K	Sell	738 -1	-0.1%	-$167	﹤0.01%	5041
2022 Q4	$140K	Sell	739 -1	-0.1%	-$353	﹤0.01%	4948
2022 Q3	$302K	Sell	740 -1	-0.1%	-$584	﹤0.01%	4869
2022 Q2	$462K	Buy	741 +10	+1%	+$5.77K	﹤0.01%	4797
2022 Q1	$453K	Buy	731 +1	+0.1%	+$733	﹤0.01%	4900
2021 Q4	$586K	Buy	730 +4	+0.6%	+$4.05K	﹤0.01%	4832
2021 Q3	$830K	Hold	726	–	–	﹤0.01%	4607
2021 Q2	$921K	Sell	726 -153	-17%	-$201K	﹤0.01%	4541
2021 Q1	$1.43M	Buy	879 +487	+124%	+$884K	﹤0.01%	4400
2020 Q4	$317K	Hold	392	–	–	﹤0.01%	4410
2020 Q3	$405K	Hold	392	–	–	﹤0.01%	4298
2020 Q2	$490K	Hold	392	–	–	﹤0.01%	4214
2020 Q1	$409K	Hold	392	–	–	﹤0.01%	4094
2019 Q4	$369K	Hold	392	–	–	﹤0.01%	4215
2019 Q3	$381K	Hold	392	–	–	﹤0.01%	4217
2019 Q2	$345K	Hold	392	–	–	﹤0.01%	4257
2019 Q1	$412K	Hold	392	–	–	﹤0.01%	4125
2018 Q4	$606K	Buy	+392	New	+$768K	﹤0.01%	4034
2018 Q3	–	Hold	0	–	–	–	4946
2018 Q2	–	Hold	0	–	–	–	4958
2018 Q1	–	Hold	0	–	–	–	4866
2017 Q4	–	Hold	0	–	–	–	4814
2017 Q3	–	Hold	0	–	–	–	4798
2017 Q2	–	Hold	0	–	–	–	4859
2017 Q1	–	Hold	0	–	–	–	4845

Other funds holding OGEN

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

SJIM

St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

BlackRock's OGEN Position: Q1 2026 in Review

BlackRock held its Oragenics (OGEN) position steady in Q1 2026 at 703 shares worth $394. The position accounts for ﹤0.01% of the portfolio, ranked #5578.

BlackRock first reported a position in OGEN in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.43M in Q1 2021. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

BlackRock held 703 shares of Oragenics worth $394 as of Q1 2026.
BlackRock left its Oragenics share count unchanged in Q1 2026.
Oragenics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5578 holding.
BlackRock first reported a position in Oragenics in Q4 2018 and has held it in 30 quarters since.
BlackRock's Oragenics position peaked at $1.43M in Q1 2021.
19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.